TTUHSC School of Pharmacy
HomeSOPFaculty & Staff Directory

Faculty & Staff Details

Profile for Ronald Hall, II

Ronald Hall

Ronald Hall, II

  • Associate Professor
Office Phone: 214-654-9404 ext 231
Mail Address: 5920 Forest Park Rd Ste 400
Dallas TX 75235-6418


Dr. Hall serves as the program director for the Dose Optimization and Outcomes Research (DOOR) progam. The DOOR program focuses on providing evidence to optimize the dosing and outcomes of medications for obese patients. Dr. Hall was selected as a National Institutes of Health Clinical Research Scholar in 2006. He was also the recipient of the 2008 Young Alumni Award from the St. Louis College of Pharmacy.

Research Interests

obesity, pharmacokinetics, antimicrobial, cancer, outcomes research

Selected Publications:

  • Hall RG. Evolving Larger: Dosing Anti-Tuberculosis (TB) Drugs in an Obese World. Current Pharmaceutical Design 2016;21(32):4748-51.
  • Payne KD, Hall RG. Dosing of antifungal agents in obese people. Expert Reviews of Anti-Infective Therapy 2015.
  • Lee YR, Houngue C, Hall RG. Treatment of community-acquired pneumonia.. Expert review of anti-infective therapy 2015;:1-13.
  • Pasipanodya JP, Hall, 2nd RG, Gumbo T. In silico-derived bedside formula for individualized micafungin dosing for obese patients in the age of deterministic chaos.. Clinical pharmacology and therapeutics 2015;97(3):292-7.
  • Alvarez CA, Giuliano CA, Haase KK, Thompson KA, Frei CR, Forcade NA, Brouse SD, Mortensen EM, Bell TE, Bedimo RJ, Toups NM, Hall, 2nd RG. Empiric weight-based vancomycin in intensive care unit patients with methicillin-resistant Staphylococcus aureus bacteremia.. The American journal of the medical sciences 2014;348(5):371-6.